163 related articles for article (PubMed ID: 18721770)
1. HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors.
Duquesnoy R; Spellman S; Haagenson M; Wang T; Horowitz MM; Oudshoorn M
Biol Blood Marrow Transplant; 2008 Sep; 14(9):1064-1071. PubMed ID: 18721770
[TBL] [Abstract][Full Text] [Related]
2. High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities.
Passweg JR; Schanz U; Chalandon Y; Güngör T; Baldomero H; Heim D; Nair G; Medinger M; Masouridi-Levrat S; de Faveri GN; Tiercy JM;
Bone Marrow Transplant; 2015 Sep; 50(9):1201-5. PubMed ID: 26052916
[TBL] [Abstract][Full Text] [Related]
3. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
[TBL] [Abstract][Full Text] [Related]
4. HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation.
Wade JA; Hurley CK; Takemoto SK; Thompson J; Davies SM; Fuller TC; Rodey G; Confer DL; Noreen H; Haagenson M; Kan F; Klein J; Eapen M; Spellman S; Kollman C
Blood; 2007 May; 109(9):4064-70. PubMed ID: 17202313
[TBL] [Abstract][Full Text] [Related]
5. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.
Duquesnoy RJ; Takemoto S; de Lange P; Doxiadis II; Schreuder GM; Persijn GG; Claas FH
Transplantation; 2003 Mar; 75(6):884-9. PubMed ID: 12660519
[TBL] [Abstract][Full Text] [Related]
6. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
[TBL] [Abstract][Full Text] [Related]
7. Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants.
Spellman S; Warden MB; Haagenson M; Pietz BC; Goulmy E; Warren EH; Wang T; Ellis TM
Biol Blood Marrow Transplant; 2009 Jul; 15(7):856-63. PubMed ID: 19539218
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
Przepiorka D; Saliba R; Cleary K; Fischer H; Tonai R; Fritsche H; Khouri IF; Folloder J; Ueno NT; Mehra R; Ippoliti C; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Anderlini P; Andersson BS; Champlin R
Biol Blood Marrow Transplant; 2000; 6(2A):190-7. PubMed ID: 10816027
[TBL] [Abstract][Full Text] [Related]
9. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
10. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.
Kröger N; Zabelina T; Binder T; Ayuk F; Bacher U; Amtsfeld G; Lellek H; Schrum J; Erttmann R; Eiermann T; Zander A
Biol Blood Marrow Transplant; 2009 Apr; 15(4):454-62. PubMed ID: 19285633
[TBL] [Abstract][Full Text] [Related]
11. Association of polymorphic MHC microsatellites with GVHD, survival, and leukemia relapse in unrelated hematopoietic stem cell transplant donor/recipient pairs matched at five HLA loci.
Li S; Kawata H; Katsuyama Y; Ota M; Morishima Y; Mano S; Kulski JK; Naruse T; Inoko H
Tissue Antigens; 2004 Apr; 63(4):362-8. PubMed ID: 15009808
[TBL] [Abstract][Full Text] [Related]
12. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
[TBL] [Abstract][Full Text] [Related]
13. Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation.
Fernandez-Viña MA; Wang T; Lee SJ; Haagenson M; Aljurf M; Askar M; Battiwalla M; Baxter-Lowe LA; Gajewski J; Jakubowski AA; Marino S; Oudshoorn M; Marsh SG; Petersdorf EW; Schultz K; Turner EV; Waller EK; Woolfrey A; Umejiego J; Spellman SR; Setterholm M
Blood; 2014 Feb; 123(8):1270-8. PubMed ID: 24408320
[TBL] [Abstract][Full Text] [Related]
14. Donor selection in a pediatric stem cell transplantation cohort using PIRCHE and HLA-DPB1 typing.
Stenger W; Künkele A; Niemann M; Todorova K; Pruß A; Schulte JH; Eggert A; Oevermann L
Pediatr Blood Cancer; 2020 Mar; 67(3):e28127. PubMed ID: 31850671
[TBL] [Abstract][Full Text] [Related]
15. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors.
Greinix HT; Faé I; Schneider B; Rosenmayr A; Mitterschiffthaler A; Pelzmann B; Kalhs P; Lechner K; Mayr WR; Fischer GF
Bone Marrow Transplant; 2005 Jan; 35(1):57-62. PubMed ID: 15531903
[TBL] [Abstract][Full Text] [Related]
16. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.
Flomenberg N; Baxter-Lowe LA; Confer D; Fernandez-Vina M; Filipovich A; Horowitz M; Hurley C; Kollman C; Anasetti C; Noreen H; Begovich A; Hildebrand W; Petersdorf E; Schmeckpeper B; Setterholm M; Trachtenberg E; Williams T; Yunis E; Weisdorf D
Blood; 2004 Oct; 104(7):1923-30. PubMed ID: 15191952
[TBL] [Abstract][Full Text] [Related]
17. Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts.
Drobyski WR; Klein J; Flomenberg N; Pietryga D; Vesole DH; Margolis DA; Keever-Taylor CA
Blood; 2002 Feb; 99(3):806-14. PubMed ID: 11806980
[TBL] [Abstract][Full Text] [Related]
18. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
Bryan CF; Chadha V; Warady BA
Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
[TBL] [Abstract][Full Text] [Related]
19. HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research.
Verneris MR; Lee SJ; Ahn KW; Wang HL; Battiwalla M; Inamoto Y; Fernandez-Vina MA; Gajewski J; Pidala J; Munker R; Aljurf M; Saber W; Spellman S; Koreth J
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1783-9. PubMed ID: 26055300
[TBL] [Abstract][Full Text] [Related]
20. Dynamic Detection of Anti-Human Leukocyte Antigen (HLA) Antibodies but not HLA-DP Loci Mismatches Can Predict Acute Graft-versus-Host Disease and Overall Survival in HLA 12/12-Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies.
Pan Z; Yuan X; Li Y; Wu X; Zhu W; Bao X; Zhao Q; He J
Biol Blood Marrow Transplant; 2016 Jan; 22(1):86-95. PubMed ID: 26283096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
